ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.65
0.48%
US Tech 100
18,318.00
0.95%
S&P 500
5,304.72
0.70%
US Dollar vs CAD
1.36595
-0.13%
Bitcoin
68,575.91
0.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) News

BVX

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:BVX
DateTimeSourceHeadlineSymbolCompany
04/17/20248:23AMAlliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
04/17/20241:00AMRNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
03/28/20242:00AMRNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
01/04/20246:30AMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
01/04/20246:30AMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
01/04/20241:00AMUK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
12/05/20235:08AMUK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
11/30/20236:08AMAlliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
11/30/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
11/22/202311:14AMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
11/15/20237:05AMAlliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
11/15/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
10/12/20236:04AMAlliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
10/12/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
10/03/20236:06AMAlliance NewsAlliance NewsBivictrix hires new CFO as Alex Hughes steps down after seven monthsLSE:BVXBivictrix Therapeutics Plc
10/03/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO and CBOLSE:BVXBivictrix Therapeutics Plc
09/19/202311:30AMAlliance NewsAlliance NewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises moneyLSE:BVXBivictrix Therapeutics Plc
09/19/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
08/31/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Total Voting RightsLSE:BVXBivictrix Therapeutics Plc
08/23/20233:30AMAlliance NewsAlliance NewsBivictrix Therapeutics granted US patent for cancer drug BVX001LSE:BVXBivictrix Therapeutics Plc
08/23/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC US Patent GrantedLSE:BVXBivictrix Therapeutics Plc
08/17/20231:00AMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
08/16/202312:00PMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
08/11/202310:17AMUK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
08/08/202311:18AMUK RegulatoryBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
07/19/20231:30PMAlliance NewsAlliance NewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraiseLSE:BVXBivictrix Therapeutics Plc
07/19/202312:16PMUK RegulatoryBiVictriX Therapeutics PLC Result of Conditional FundraiseLSE:BVXBivictrix Therapeutics Plc
07/19/20238:12AMAlliance NewsAlliance NewsIN BRIEF: Bivictrix to raise more than GBP2 million via placingLSE:BVXBivictrix Therapeutics Plc
07/19/20236:31AMUK RegulatoryBiVictriX Therapeutics PLC Proposed Fundraise in excess of GBP2 millionLSE:BVXBivictrix Therapeutics Plc
07/17/20237:57AMAlliance NewsAlliance NewsBivictrix Therapeutics hails positive data in final leukaemia studyLSE:BVXBivictrix Therapeutics Plc
 Showing the most relevant articles for your search:LSE:BVX

Your Recent History

BIT
F18146
Vontobel Financial Produ...
BOV
L1EG34
Leggett Platt
BIT
F12475
Vontobel Financial Produ...
EU
P789S
P789S
NASDAQ
FWSBCX
Strategic International ...
NYSE
PGRU
PropertyGuru
NYSE
HIW
Highwoods Properties
NYSE
PRE-I
PartnerRe
NYSE
CNDA
Concord Acquisition Corp...
COIN
TKXETH
Tokenize Xchange Emblem
DGFX
RETUSDT
Renewable Energy Token
BIT
FLV025
Vontobel
XE
GLJ
Grenke
BIT
S30152
Societe Generale Effekten
BOV
EVENF720
EVENF720 Ex:6,7
BOV
BSDV39
Global X Funds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved